Therapy Areas: Central Nervous System
12 January 2018 - - The UK Medicines and Healthcare Regulatory Agency (MHRA) has accepted Paris, France-based clinical-stage biopharma company GenSight Biologics' (Paris, Euronext: SIGHT) clinica...
11 January 2018 - - Thousand Oaks, California-based human therapeutics developer Amgen (NASDAQ: AMGN) and Brussels, Belgium-based biopharmaceutical company UCB's (Euronext Brussels: UCB) marketin...
10 January 2018 - Cingulate Therapeutics LLC, a clinical stage biopharmaceutical company focused on the development of new and innovative products utilising its precision timed release drug delivery p...
9 January 2018 - - Osaka, Japan-based R and D-driven pharmaceutical company Takeda Pharmaceutical Company Ltd. (TSX: 4502) and South San Francisco, California-based neurodegenerative disease therapeut...
5 January 2018 - - Athens, Georgia-based exosome specialist ArunA Biomedical has launched a new class of cell-free exosome biologics to treat central nervous system and neurodegenerative disorders, th...
4 January 2018 - - Seattle, Washington-based small-molecule and protein therapeutics specialist Omeros Corp. (NASDAQ: OMER) has reached agreement with the US Food and Drug Administration on its p...